125962-37-0Relevant articles and documents
CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF
-
Paragraph 0269-0272, (2021/05/21)
An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1] (in the formula, R1 represents a halogen atom, an amino group which may be substituted, a C1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R2 represents a hydrogen atom or an amino protecting group; R3 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R4 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like); or a salt thereof.
Novel cyclobutane Derivatives, processes for their preparation and pharmaceutical compositions comprising them
-
, (2008/06/13)
The invention is directed to cyclobutane derivatives represented by general formula (I): wherein A represents a hydrogen atom, a hydroxy group, an azido group or an amino group; and B represents a purine residue or a pyrimidine residue. The cyclobutane de